Found: 7
Select item for more details and to access through your institution.
FOXP3 Transcription Factor: A Candidate Marker for Susceptibility and Prognosis in Triple Negative Breast Cancer.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
FOXP3 Transcription Factor: A Candidate Marker for Susceptibility and Prognosis in Triple Negative Breast Cancer.
- Published in:
- BioMed Research International, 2014, v. 2014, p. 1, doi. 10.1155/2014/341654
- By:
- Publication type:
- Article
Authors' reply to the comment "Transforming growth factor beta receptor II (TGFBR2) promoter region polymorphism".
- Published in:
- 2020
- By:
- Publication type:
- Letter
Transforming growth factor beta receptor II (TGFBR2) promoter region polymorphism in Brazilian breast cancer patients: association with susceptibility, clinicopathological features, and interaction with TGFB1 haplotypes.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 178, n. 1, p. 207, doi. 10.1007/s10549-019-05370-1
- By:
- Publication type:
- Article
Germline APOBEC3B deletion influences clinicopathological parameters in luminal-A breast cancer: evidences from a southern Brazilian cohort.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2020, v. 146, n. 6, p. 1523, doi. 10.1007/s00432-020-03208-8
- By:
- Publication type:
- Article
Glutathione S-transferases deletions may act as prognosis and therapeutic markers in breast cancer.
- Published in:
- Clinical & Experimental Medicine, 2018, v. 18, n. 1, p. 27, doi. 10.1007/s10238-017-0461-6
- By:
- Publication type:
- Article
Genetic Polymorphism and Expression of CXCR4 in Breast Cancer.
- Published in:
- Analytical Cellular Pathology: Cellular Oncology, 2015, v. 2015, p. 1, doi. 10.1155/2015/289510
- By:
- Publication type:
- Article